Financial reports
NT 10-K
Notice of late annual filing
31 Mar 20
10-Q
2019 Q3
Quarterly report
12 Nov 19
10-Q
2019 Q2
Quarterly report
8 Aug 19
10-Q
2019 Q1
Quarterly report
9 May 19
10-K
2018 FY
Annual report
6 Mar 19
10-Q
2018 Q3
Quarterly report
9 Nov 18
10-Q
2018 Q2
Quarterly report
8 Aug 18
10-Q
2018 Q1
Quarterly report
9 May 18
Current reports
8-K
Entry into a Material Definitive Agreement
2 Apr 20
8-K
Valeritas Receives Court Approval of Sale of Business to Zealand Pharma
20 Mar 20
8-K
Entry into a Material Definitive Agreement
18 Mar 20
8-K
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
16 Mar 20
8-K
Departure of Directors or Certain Officers
28 Feb 20
8-K
Entry into a Material Definitive Agreement
14 Feb 20
8-K
Valeritas Announces Agreement for Zealand Pharma to Acquire Business and Retain Employees
10 Feb 20
8-K
Departure of Directors or Certain Officers
10 Jan 20
8-K
Departure of Directors or Certain Officers
23 Dec 19
8-K
Valeritas Experiences a Temporary Supply Disruption Resulting in Revised Preliminary Financial Results for 2019 Fourth Quarter and Full Year
20 Dec 19
Registration and prospectus
15-12B
Securities registration termination
3 Apr 20
POS AM
Prospectus update (post-effective amendment)
31 Mar 20
POS AM
Prospectus update (post-effective amendment)
31 Mar 20
POS AM
Prospectus update (post-effective amendment)
30 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
30 Mar 20
424B5
Prospectus supplement for primary offering
30 Mar 20
Proxies
DEF 14A
Definitive proxy
9 Apr 19
PRE 14A
Preliminary proxy
29 Mar 19
DEF 14A
Definitive proxy
22 Jun 18
DEF 14A
Definitive proxy
5 May 17
DEF 14A
Definitive proxy
15 Feb 17
PRE 14A
Preliminary proxy
26 Jan 17
Other
EFFECT
Notice of effectiveness
3 Apr 20
EFFECT
Notice of effectiveness
3 Apr 20
EFFECT
Notice of effectiveness
3 Apr 20
UPLOAD
Letter from SEC
8 Oct 19
CORRESP
Correspondence with SEC
4 Oct 19
UPLOAD
Letter from SEC
24 Sep 19
EFFECT
Notice of effectiveness
10 Sep 19
CORRESP
Correspondence with SEC
5 Sep 19
CORRESP
Correspondence with SEC
30 Aug 19
UPLOAD
Letter from SEC
29 Aug 19
Ownership
SC 13G/A
Beneficial ownership report (amended)
14 Feb 20
3
Melanie R. Hansen
23 Jan 20
4
Steven Boyd
23 Dec 19
SC 13G/A
Valeritas Holdings Inc.
23 Dec 19
4
Change in insider ownership
2 Oct 19
SC 13D/A
Valeritas Holdings Inc.
2 Oct 19
SC 13G/A
Valeritas Holdings Inc.
10 Sep 19
4
Steven Boyd
28 May 19
4
Steven Boyd
21 May 19
4
Joseph M Mandato
16 May 19